Literature DB >> 6323142

Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells.

E L Hohmann, A H Tashjian.   

Abstract

We have previously reported that vasoactive intestinal peptide (VIP) stimulates bone resorption in organ culture via a cAMP-dependent mechanism. Here we describe functional receptors for VIP on a clonal line of human osteosarcoma cells, SaOs-2. SaOs-2 cells respond to VIP with an increase in cAMP. The effect was rapid (2 min) and dose dependent from 0.15-15 nM VIP, with half-maximal stimulation at 1.4 nM. SaOs-2 cells produce prostaglandin E2 (PGE2) and respond to exogenous PGE2 with increases in cAMP approximately one third as great as those induced by VIP. However, the VIP-stimulated increases in cAMP occurred without detectable increases in PGE2 production, and increases in cAMP were unaffected by the cyclooxygenase inhibitor indomethacin. SaOs-2 cells pretreated with VIP for 24 h were significantly less responsive to a second acute challenge with VIP, but retained their ability to respond to PGE2. Similarly, pretreatment with PGE2 induced homologous desensitization to PGE2, but had no effect on the VIP-stimulated increase in cAMP. These patterns of response paralleled those previously described in whole bone in organ culture. Binding studies with [125I]VIP demonstrated specific, saturable, high affinity receptors for VIP on SaOs-2 cells. Scatchard analysis of [125I]VIP binding at 37 C resulted in a curvilinear plot. Analysis based upon the assumption of two independent binding sites gave Kd values of 0.44 and 17 nM for high and low affinity binding sites, respectively. The numbers of high and low affinity sites per cell were determined to be 8,500 and 57,000, respectively. Binding of [125I]VIP was partially inhibited by two related peptides, secretin and PHI-27, but not by PTH, calcitonin or a variety of unrelated peptides. We conclude that the action of VIP on human SaOs-2 cells is similar to that observed in intact mouse calvaria, and that these cells provide a good model for the study of the initial steps of VIP action in bone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323142     DOI: 10.1210/endo-114-4-1321

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum.

Authors:  S E Asmus; S Parsons; S C Landis
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 2.  Is bone a target-tissue for the nervous system? New advances on the understanding of their interactions.

Authors:  J M García-Castellano; P Díaz-Herrera; J A Morcuende
Journal:  Iowa Orthop J       Date:  2000

3.  Neuroendocrine peptides in bone.

Authors:  A Bjurholm
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

4.  Neurotransmitter regulation of cytosolic calcium in osteoblast-like bone cells.

Authors:  H Kumagai; H Sakamoto; S Guggino; C R Filburn; B Sacktor
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

5.  Protein kinase A-dependent inhibition of alkaline phosphatase release by SaOS-2 human osteoblastic cells: studies in new mutant cell lines that express a cyclic AMP-resistant phenotype.

Authors:  S Fukayama; A K Kearns; R M Skurat; A H Tashjian; F R Bringhurst
Journal:  Cell Regul       Date:  1991-11

6.  Fixation and demineralization of bone tissue for immunohistochemical staining of neuropeptides.

Authors:  A Bjurholm; A Kreicbergs; M Schultzberg
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

7.  Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat.

Authors:  E L Hill; R Elde
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

8.  Isolation and characterization of human embryonic osteoblasts.

Authors:  A Oliva; G Marrone; F Della Ragione; V Riccio; R Palumbo; F Rossano; V Zappia
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

9.  Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines.

Authors:  U H Lerner; P Lundberg; M Ransjö; P Persson; R Håkanson
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

10.  Characterization of human bone cells in culture.

Authors:  B Auf'mkolk; P V Hauschka; E R Schwartz
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.